Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Predicted Infection Risk for Aerosol Transmission of SARS-CoV-2

Martin Kriegel, Udo Buchholz, Petra Gastmeier, Peter Bischoff, Inas Abdelgawad, Anne Hartmann
doi: https://doi.org/10.1101/2020.10.08.20209106
Martin Kriegel
1Technical University of Berlin, Hermann-Rietschel-Institut
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.kriegel@tu-berlin.de
Udo Buchholz
2Robert-Koch-Institute, Department for Infectious Disease Epidemiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petra Gastmeier
3Charité-University Medicine Berlin, Institute for Hygiene and Environmental Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bischoff
3Charité-University Medicine Berlin, Institute for Hygiene and Environmental Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inas Abdelgawad
4Public Health Department Berlin Spandau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Hartmann
1Technical University of Berlin, Hermann-Rietschel-Institut
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Currently, the respiratory route is seen as the most important transmission path for SARS-CoV-2. In this investigation, models of other researchers which had the aim of predicting an infection risk for exposed persons in a room through aerosols emitted by an infectious case-patient were extended. As a novelty – usually neglected – parameters or boundary conditions, namely the non-stationarity of aerosols and the half-life of the aerosolized virus, were included and a new method for determining the quanta emission rate based on measurements of the particle emission rate and respiratory rate at different types of activities was implemented.

As a second step, the model was applied to twelve outbreaks to compare the predicted infection risk with the observed attack rate. To estimate a “credible interval” of the predicted infection risk, the quanta emission rate, the respiratory rate as well as the air volume flow were varied.

In nine out of twelve outbreaks, the calculated predicted infection risk via aerosols was found to be in the range of the attack rate (with the variation of the boundary conditions) and reasons for the observed larger divergence were discussed.

The validation was considered successful and therefore the use of the model could be recommended to predict the risk of an infection via aerosols in given situations. Furthermore, appropriate preventive measures can be designed.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding has been received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No ethical committee approval necessary

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • correction in Table 1

Data Availability

all data presented in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 05, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Predicted Infection Risk for Aerosol Transmission of SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Predicted Infection Risk for Aerosol Transmission of SARS-CoV-2
Martin Kriegel, Udo Buchholz, Petra Gastmeier, Peter Bischoff, Inas Abdelgawad, Anne Hartmann
medRxiv 2020.10.08.20209106; doi: https://doi.org/10.1101/2020.10.08.20209106
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Predicted Infection Risk for Aerosol Transmission of SARS-CoV-2
Martin Kriegel, Udo Buchholz, Petra Gastmeier, Peter Bischoff, Inas Abdelgawad, Anne Hartmann
medRxiv 2020.10.08.20209106; doi: https://doi.org/10.1101/2020.10.08.20209106

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Occupational and Environmental Health
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1264)
  • Dentistry and Oral Medicine (207)
  • Dermatology (148)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
  • Epidemiology (10056)
  • Forensic Medicine (5)
  • Gastroenterology (502)
  • Genetic and Genomic Medicine (2486)
  • Geriatric Medicine (240)
  • Health Economics (482)
  • Health Informatics (1653)
  • Health Policy (757)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (538)
  • Infectious Diseases (except HIV/AIDS) (11896)
  • Intensive Care and Critical Care Medicine (627)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2304)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1259)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (737)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2295)
  • Public and Global Health (4850)
  • Radiology and Imaging (846)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (657)
  • Rheumatology (289)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (228)
  • Surgery (273)
  • Toxicology (44)
  • Transplantation (131)
  • Urology (100)